CVS

CVS Health Corporation

CVS Health Corp operates in the healthcare sector. Its primary business is that of operating retail pharmacies.

CVS Health Corporation (CVS) is rated C+ (2.7/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Value (B); its weakest is Growth (C-). The rating has held at C+ for 5 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.7 / 5.0
C+
Value
B
Factor Score 3.2 / 5.0
Growth
C-
Factor Score 2.0 / 5.0
Profitability
B-
Factor Score 2.9 / 5.0
Momentum
B-
Factor Score 3.0 / 5.0
Revisions
C
Factor Score 2.4 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio 10.4
EV / EBITDA 10.1
Rev Growth YoY 5.4%
Gross Margin 13.7%
Price Return 3M -4.3%
Price Return 12M 14.7%
Catalyst Signal +0.15
Market Cap $114.3B
TTM Revenue $418.2B
Price / Sales 0.3
ROE 14.4%

Historical Factor Score Progression

Held C+ for 5 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-16 B (3.2) C- (2.0) B- (2.9) B- (3.0) C (2.4) C+ (2.7)
2026-11-12 B (3.2) C- (2.0) B- (2.9) C+ (2.8) C (2.4) C+ (2.7)
2026-11-09 B (3.2) C- (2.0) B- (2.9) C+ (2.8) C+ (2.5) C+ (2.7)
2026-11-06 B- (3.1) C+ (2.7) B- (2.9) C+ (2.7) C (2.4) C+ (2.8)
2026-11-05 B- (3.1) C+ (2.7) B- (2.9) C+ (2.6) C+ (2.7) C+ (2.8)
Page 1 of 12
…